Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03)
Funding Amount
Up to US $200,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Who is eligible?Early stage investigators in AD/ADRD research and established researchers who are not currently doing AD/ADRD research.
Overview
The Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03) aims to support innovative research to enhance the prevention, diagnosis, treatment, and care for Alzheimer's disease and related dementias. Launched by the NIA, this program nurtures early-stage and established researchers, providing essential networking and mentorship opportunities to foster advancements in Alzheimer's research, ultimately improving the lives of patients and caregivers.
Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03)
This National Institute on Aging (NIA) Small Research Grant Program supports important and innovative research in areas in which more scientific investigation is needed to improve the prevention, diagnosis, treatment and care for Alzheimer's disease and related dementias (AD/ADRD).
Motivated by a deep interest in improving the lives of those affected by Alzheimer’s disease, The Rosalinde and Arthur Gilbert Foundation and the American Federation for Aging Research (AFAR), launched the New Investigator Awards in Alzheimer’s Disease research program in 2007. Since then, The Rosalinde and Arthur Gilbert Foundation has invested almost $4 million to support New Investigators in the United States and Israel conducting Alzheimer’s disease research.
In 2017, The Rosalinde and Arthur Gilbert Foundation and AFAR published the report, “New Investigator Awards in Alzheimer’s Disease Research: A Successful Model for Investing in Futures.” The report looks at the first ten years of the New Investigator Awards in Alzheimer’s Disease research program and describes the program’s evolution, accomplishments, responsiveness to emerging needs in the field, and lessons learned.
In 2018, the NIA launched the Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease which will continue to support the next generation of Alzheimer’s disease researchers. These intimate gatherings, typically attended by current grantees and alumni, provide the investigators with access to colleagues who are working on similar scientific issues related to Alzheimer’s disease, though often in different disciplines. Alumni participation further stimulates the development of scholarship, leadership and informal mentorship to the current investigators, and strengthens the network among alumni and current investigators.
Eligibility
Who is eligible?Early stage investigators in AD/ADRD research and established researchers who are not currently doing AD/ADRD research.
What American Federation for Aging Research Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 57
- Total given
- $12.81M
- Median grant
- $150K
- Range
- $7,500–$905K
- By dollars: New York 17%, Massachusetts 16%, California 10%. Top recipient cities: New York, NY; Philadelphia, PA; La Jolla, CA.
- 0% of grants with a stated purpose were for general or operating support.
- 35% of recipients were new grantees, not repeat recipients.
Example grants
Rockefeller University · New York, NY
Scientific research
$905K
University of California San Diego · La Jolla, CA
Scientific research
$776K
Boston University · Chestnut Hill, MA
Scientific research/conference
$758K
Pennsylvania State University · State College, PA
Scientific research
$750K
University of Minnesota · Minneapolis, MN
Scientific research
$750K
Focus Areas & Funding Uses
Fields of Work
- Alzheimer's
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
November 10, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $1,000,000
Deadline
May 7, 2028
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $1,500,000
Deadline
November 5, 2027
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$2,650,000 total
Deadline
October 22, 2026
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
Ready to apply for Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03). Now let's win it.